The basal-like tumor group is also called triple-negative breast cancer (TNBC) because these tumors usually lack estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression [2]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.